Pay in 4 interest-free payments of $49.09 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
constitutive activation of this pathway is associated with uncontrolled cellular proliferation and has been observed in a variety of cancers
Clinical utility
Gypenoside III
Mitchell JA
2-dihydroquinolin-4-yl)propanoic acid
SMND-309 - CAS# 1065559-56-9 ite N-desmethyl Netupitant constitutive activation of this pathwaySMND 309 is a novel derivate of salvianolic acid B. SMND 309 promotes neuron survival through the activation of the PI3K Akt CREB signalling pathway. SMND 309 protects rat brains ischemia and reperfusion injury by targeting the JAK2 STAT3 pathway. SMND 309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor STAT3 VEGF pathways. Product information CAS Number: 1065559 56 9 Molecular Weight: 358. 30
US$ 30.00
US$ 15.00
US$ 10.00
US$ 10.00
US$ 10.00
US$ 20.00